During this webinar, presenters will look at surgeon readiness for operating following neoadjuvant immunotherapy and targeted therapies, while sharing new knowledge of pathology review and standardized assessment of pathologic complete response (pCR). The program reinforces the rationale for adjuvant therapy continuation, drawing on evidence from AEGEAN, including event-free survival outcomes, pathology-linked insights, and postoperative treatment sequencing. The session also defines the surgeon’s role in educating patients across the full treatment journey.
In his 2026 STS Annual Meeting presentation, Defining Success in Surgical Treatment of Afib: The Need for Standardization, Dr. Michael Bowdish discussed the development of a new quality measure for the treatment of preoperative atrial fibrillation and the evidence for long-term benefits to patients whose AFib is treated during cardiac surgery.
The latest techniques and management strategies in cardiovascular and thoracic critical care and enhanced recovery after surgery for the entire care team.
A world-class, international event that will explore the latest developments and best practices in coronary artery disease, congenital heart disease, thoracic aortic disease, atrial fibrillation, and the surgical management of heart failure
This webinar reviews significant lung infections such as mucormycosis, tuberculosis, and hydatidosis. Our expert panel of speakers from the United States and Latin America will discuss controversial topics on these three diseases, state-of-the-art management, and different options in surgical approach.
This 30-minute session expands on the STS Roadmap to Mobile Lung Cancer Screenings and examines the intricacies of mobile cancer screening units and how they operate. The event is open to all interested in creating or expanding a mobile cancer screening initiative at their institution.
Moderator
Elliot L. Servais, MD Lahey Hospital & Medical Center Burlington, MA
